CN Stock MarketDetailed Quotes

Hefei Lifeon Pharmaceutical (003020)

Watchlist
  • 21.74
  • -0.34-1.54%
Market Closed May 15 15:00 CST
4.13BMarket Cap25.49P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Hefei Lifeon Pharmaceutical (003020) Income Statement

All
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q9)Sep 30, 2025
(Q6)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
Total operating revenue
-0.87%357.1M
2.33%1.55B
-3.95%1.08B
-4.80%732.44M
7.98%360.23M
-20.11%1.52B
-26.20%1.13B
-39.32%769.33M
-58.90%333.62M
-26.31%1.9B
Operating revenue
-0.87%357.1M
2.33%1.55B
-3.95%1.08B
-4.80%732.44M
7.98%360.23M
-20.11%1.52B
-26.20%1.13B
-39.32%769.33M
-58.90%333.62M
-26.31%1.9B
Other operating revenue
----
27.05%38.52M
----
55.83%18.33M
----
112.79%30.32M
----
92.44%11.77M
----
60.75%14.25M
Total operating cost
-2.09%316.97M
4.09%1.41B
-2.16%979.33M
-3.25%660.11M
5.19%323.75M
-19.41%1.36B
-26.27%1B
-39.88%682.32M
-57.86%307.76M
-29.21%1.68B
Operating cost
-8.18%121.91M
17.62%550.81M
13.16%382.96M
19.54%261.87M
28.42%132.78M
-49.22%468.29M
-58.50%338.42M
-69.65%219.06M
-79.93%103.4M
-42.90%922.2M
Operating tax surcharges
2.86%5.66M
10.83%24.86M
5.27%17.54M
-8.39%10.69M
14.46%5.5M
22.34%22.43M
30.15%16.66M
16.91%11.67M
-15.14%4.8M
14.90%18.34M
Operating expense
1.76%153.42M
-5.48%654.19M
-13.24%458.55M
-18.37%302.49M
-4.83%150.76M
15.65%692.13M
23.87%528.54M
11.67%370.54M
-13.61%158.41M
-2.91%598.45M
Administration expense
9.85%17.42M
-13.98%70.16M
-23.51%48.88M
-25.71%33.3M
-12.14%15.86M
31.64%81.56M
37.25%63.91M
44.25%44.82M
19.01%18.05M
4.76%61.96M
Financial expense
181.48%183.8K
359.14%586.34K
198.13%365.97K
111.60%59.28K
48.85%-225.56K
93.13%-226.27K
90.11%-372.94K
78.70%-510.91K
71.63%-440.98K
7.13%-3.29M
-Interest expense (Financial expense)
50.98%399.14K
21.87%2.34M
16.98%1.08M
68.35%1.4M
14.75%264.36K
49.89%1.92M
73.96%926.62K
-33.14%832.41K
106.40%230.38K
43.93%1.28M
-Interest Income (Financial expense)
54.18%-264.54K
15.03%-1.89M
22.91%-1.28M
-3.35%-1.42M
32.49%-577.33K
52.22%-2.22M
62.01%-1.67M
62.94%-1.37M
45.08%-855.22K
-5.90%-4.65M
Research and development
-3.65%18.38M
20.70%110.78M
32.02%71.04M
40.77%51.71M
-18.97%19.08M
8.03%91.78M
-10.22%53.81M
-14.17%36.73M
87.78%23.55M
15.11%84.96M
Credit Impairment Loss
97.77%-31.15K
76.31%-887.17K
46.68%-1.05M
24.62%-1.61M
-76.73%-1.4M
-77.85%-3.74M
48.83%-1.97M
63.04%-2.13M
49.93%-790.34K
-780.30%-2.11M
Asset Impairment Loss
73.75%-695.05K
12.74%-10.58M
-6.03%-9.6M
17.42%-7.89M
-27.91%-2.65M
-31.81%-12.13M
-64.63%-9.05M
-202.75%-9.55M
14.19%-2.07M
-143.32%-9.2M
Adjustment items of total operating cost
---0.01
----
----
----
----
----
----
----
----
----
Other net revenue
-78.05%1.68M
160.81%39.69M
382.65%35.75M
15,510.68%28.7M
141.47%7.63M
-58.97%15.22M
-69.70%7.41M
-98.71%183.86K
189.80%3.16M
-1.14%37.09M
Fair value change income
806.10%255.92K
-90.69%149.01K
-92.99%87.46K
-90.27%141.88K
-103.73%-36.24K
407.47%1.6M
-47.78%1.25M
5.67%1.46M
25,297.63%972.79K
926.44%315.52K
Invest income
-128.42%-906.8K
143.10%27.72M
206.13%27.63M
395.96%26.12M
-7.06%3.19M
-58.52%11.4M
-67.18%9.03M
-73.39%5.27M
1,038.88%3.43M
-14.88%27.49M
-Including: Investment income associates
-168.43%-1.75M
-60.53%3.09M
----
----
32.21%2.56M
639.45%7.83M
----
----
392.73%1.94M
126.44%1.06M
Asset deal income
----
-108.35%-1.68K
-96.19%3.54K
-98.16%1.77K
----
--20.1K
--92.97K
2,621.34%96.4K
----
----
Other revenue
-64.18%3.05M
28.93%23.29M
131.58%18.68M
136.40%11.93M
427.78%8.52M
-12.27%18.07M
106.33%8.07M
155.81%5.05M
91.41%1.61M
74.10%20.59M
Operating profit
-5.24%41.8M
2.46%182.11M
4.21%137.1M
15.86%101.02M
52.02%44.11M
-30.37%177.73M
-31.24%131.56M
-40.69%87.2M
-62.76%29.02M
6.34%255.27M
Add:Non operating Income
-83.12%25.95K
-24.47%826.79K
-52.44%216.97K
-71.82%111.34K
-35.23%153.68K
-65.20%1.09M
79.58%456.2K
107.19%395.08K
113.46%237.28K
641.47%3.15M
Less:Non operating expense
442.71%514.15K
-83.77%1.14M
-34.72%456.77K
-60.57%255.28K
-61.18%94.74K
602.15%7.01M
3.21%699.74K
15.28%647.46K
25,623.96%244.05K
52.30%998.83K
Total profit
-6.47%41.31M
5.81%181.8M
4.22%136.86M
16.03%100.88M
52.26%44.17M
-33.25%171.82M
-31.21%131.32M
-40.71%86.94M
-62.83%29.01M
7.34%257.42M
Less:Income tax cost
23.71%6.05M
-5.64%18.24M
-12.21%13.75M
-14.62%9.35M
215.04%4.89M
-17.84%19.34M
-13.35%15.66M
-29.44%10.95M
-86.94%1.55M
-23.03%23.53M
Net profit
-10.23%35.26M
7.26%163.55M
6.45%123.11M
20.45%91.53M
43.05%39.28M
-34.80%152.48M
-33.08%115.66M
-42.05%75.99M
-58.49%27.46M
11.77%233.88M
Net profit from continuing operation
-10.23%35.26M
7.26%163.55M
6.45%123.11M
20.45%91.53M
43.05%39.28M
-34.80%152.48M
-33.08%115.66M
-42.05%75.99M
-58.49%27.46M
11.77%233.88M
Less:Minority Profit
-103.18%-32.64K
79.75%-1.64M
165.32%2.17M
190.60%1.3M
135.15%1.03M
-212.58%-8.12M
-328.33%-3.32M
---1.44M
---2.92M
--7.21M
Net profit of parent company owners
-7.74%35.29M
2.86%165.19M
1.65%120.94M
16.53%90.23M
25.94%38.25M
-29.15%160.6M
-30.57%118.98M
-40.95%77.43M
-54.08%30.37M
8.33%226.67M
Earning per share
Basic earning per share
-5.00%0.19
3.57%0.87
1.59%0.64
17.50%0.47
25.00%0.2
-28.81%0.84
-30.77%0.63
-41.18%0.4
-60.98%0.16
-11.28%1.18
Diluted earning per share
-5.00%0.19
3.57%0.87
1.59%0.64
17.50%0.47
25.00%0.2
-28.81%0.84
-30.77%0.63
-41.18%0.4
-60.98%0.16
-11.28%1.18
Other composite income
Total composite income
-10.23%35.26M
7.26%163.55M
6.45%123.11M
20.45%91.53M
43.05%39.28M
-34.80%152.48M
-33.08%115.66M
-42.05%75.99M
-58.49%27.46M
11.77%233.88M
Total composite income of parent company owners
-7.74%35.29M
2.86%165.19M
1.65%120.94M
16.53%90.23M
25.94%38.25M
-29.15%160.6M
-30.57%118.98M
-40.95%77.43M
-54.08%30.37M
8.33%226.67M
Total composite income of minority owners
-103.18%-32.64K
79.75%-1.64M
165.32%2.17M
190.60%1.3M
135.15%1.03M
-212.58%-8.12M
-328.33%-3.32M
---1.44M
---2.92M
--7.21M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
Auditor
--
Zhonghui Certified Public Accountants (Special General Partnership)
--
--
--
Zhonghui Certified Public Accountants (Special General Partnership)
--
--
--
Zhonghui Certified Public Accountants (Special General Partnership)
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q9)Sep 30, 2025(Q6)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023
Total operating revenue -0.87%357.1M2.33%1.55B-3.95%1.08B-4.80%732.44M7.98%360.23M-20.11%1.52B-26.20%1.13B-39.32%769.33M-58.90%333.62M-26.31%1.9B
Operating revenue -0.87%357.1M2.33%1.55B-3.95%1.08B-4.80%732.44M7.98%360.23M-20.11%1.52B-26.20%1.13B-39.32%769.33M-58.90%333.62M-26.31%1.9B
Other operating revenue ----27.05%38.52M----55.83%18.33M----112.79%30.32M----92.44%11.77M----60.75%14.25M
Total operating cost -2.09%316.97M4.09%1.41B-2.16%979.33M-3.25%660.11M5.19%323.75M-19.41%1.36B-26.27%1B-39.88%682.32M-57.86%307.76M-29.21%1.68B
Operating cost -8.18%121.91M17.62%550.81M13.16%382.96M19.54%261.87M28.42%132.78M-49.22%468.29M-58.50%338.42M-69.65%219.06M-79.93%103.4M-42.90%922.2M
Operating tax surcharges 2.86%5.66M10.83%24.86M5.27%17.54M-8.39%10.69M14.46%5.5M22.34%22.43M30.15%16.66M16.91%11.67M-15.14%4.8M14.90%18.34M
Operating expense 1.76%153.42M-5.48%654.19M-13.24%458.55M-18.37%302.49M-4.83%150.76M15.65%692.13M23.87%528.54M11.67%370.54M-13.61%158.41M-2.91%598.45M
Administration expense 9.85%17.42M-13.98%70.16M-23.51%48.88M-25.71%33.3M-12.14%15.86M31.64%81.56M37.25%63.91M44.25%44.82M19.01%18.05M4.76%61.96M
Financial expense 181.48%183.8K359.14%586.34K198.13%365.97K111.60%59.28K48.85%-225.56K93.13%-226.27K90.11%-372.94K78.70%-510.91K71.63%-440.98K7.13%-3.29M
-Interest expense (Financial expense) 50.98%399.14K21.87%2.34M16.98%1.08M68.35%1.4M14.75%264.36K49.89%1.92M73.96%926.62K-33.14%832.41K106.40%230.38K43.93%1.28M
-Interest Income (Financial expense) 54.18%-264.54K15.03%-1.89M22.91%-1.28M-3.35%-1.42M32.49%-577.33K52.22%-2.22M62.01%-1.67M62.94%-1.37M45.08%-855.22K-5.90%-4.65M
Research and development -3.65%18.38M20.70%110.78M32.02%71.04M40.77%51.71M-18.97%19.08M8.03%91.78M-10.22%53.81M-14.17%36.73M87.78%23.55M15.11%84.96M
Credit Impairment Loss 97.77%-31.15K76.31%-887.17K46.68%-1.05M24.62%-1.61M-76.73%-1.4M-77.85%-3.74M48.83%-1.97M63.04%-2.13M49.93%-790.34K-780.30%-2.11M
Asset Impairment Loss 73.75%-695.05K12.74%-10.58M-6.03%-9.6M17.42%-7.89M-27.91%-2.65M-31.81%-12.13M-64.63%-9.05M-202.75%-9.55M14.19%-2.07M-143.32%-9.2M
Adjustment items of total operating cost ---0.01------------------------------------
Other net revenue -78.05%1.68M160.81%39.69M382.65%35.75M15,510.68%28.7M141.47%7.63M-58.97%15.22M-69.70%7.41M-98.71%183.86K189.80%3.16M-1.14%37.09M
Fair value change income 806.10%255.92K-90.69%149.01K-92.99%87.46K-90.27%141.88K-103.73%-36.24K407.47%1.6M-47.78%1.25M5.67%1.46M25,297.63%972.79K926.44%315.52K
Invest income -128.42%-906.8K143.10%27.72M206.13%27.63M395.96%26.12M-7.06%3.19M-58.52%11.4M-67.18%9.03M-73.39%5.27M1,038.88%3.43M-14.88%27.49M
-Including: Investment income associates -168.43%-1.75M-60.53%3.09M--------32.21%2.56M639.45%7.83M--------392.73%1.94M126.44%1.06M
Asset deal income -----108.35%-1.68K-96.19%3.54K-98.16%1.77K------20.1K--92.97K2,621.34%96.4K--------
Other revenue -64.18%3.05M28.93%23.29M131.58%18.68M136.40%11.93M427.78%8.52M-12.27%18.07M106.33%8.07M155.81%5.05M91.41%1.61M74.10%20.59M
Operating profit -5.24%41.8M2.46%182.11M4.21%137.1M15.86%101.02M52.02%44.11M-30.37%177.73M-31.24%131.56M-40.69%87.2M-62.76%29.02M6.34%255.27M
Add:Non operating Income -83.12%25.95K-24.47%826.79K-52.44%216.97K-71.82%111.34K-35.23%153.68K-65.20%1.09M79.58%456.2K107.19%395.08K113.46%237.28K641.47%3.15M
Less:Non operating expense 442.71%514.15K-83.77%1.14M-34.72%456.77K-60.57%255.28K-61.18%94.74K602.15%7.01M3.21%699.74K15.28%647.46K25,623.96%244.05K52.30%998.83K
Total profit -6.47%41.31M5.81%181.8M4.22%136.86M16.03%100.88M52.26%44.17M-33.25%171.82M-31.21%131.32M-40.71%86.94M-62.83%29.01M7.34%257.42M
Less:Income tax cost 23.71%6.05M-5.64%18.24M-12.21%13.75M-14.62%9.35M215.04%4.89M-17.84%19.34M-13.35%15.66M-29.44%10.95M-86.94%1.55M-23.03%23.53M
Net profit -10.23%35.26M7.26%163.55M6.45%123.11M20.45%91.53M43.05%39.28M-34.80%152.48M-33.08%115.66M-42.05%75.99M-58.49%27.46M11.77%233.88M
Net profit from continuing operation -10.23%35.26M7.26%163.55M6.45%123.11M20.45%91.53M43.05%39.28M-34.80%152.48M-33.08%115.66M-42.05%75.99M-58.49%27.46M11.77%233.88M
Less:Minority Profit -103.18%-32.64K79.75%-1.64M165.32%2.17M190.60%1.3M135.15%1.03M-212.58%-8.12M-328.33%-3.32M---1.44M---2.92M--7.21M
Net profit of parent company owners -7.74%35.29M2.86%165.19M1.65%120.94M16.53%90.23M25.94%38.25M-29.15%160.6M-30.57%118.98M-40.95%77.43M-54.08%30.37M8.33%226.67M
Earning per share
Basic earning per share -5.00%0.193.57%0.871.59%0.6417.50%0.4725.00%0.2-28.81%0.84-30.77%0.63-41.18%0.4-60.98%0.16-11.28%1.18
Diluted earning per share -5.00%0.193.57%0.871.59%0.6417.50%0.4725.00%0.2-28.81%0.84-30.77%0.63-41.18%0.4-60.98%0.16-11.28%1.18
Other composite income
Total composite income -10.23%35.26M7.26%163.55M6.45%123.11M20.45%91.53M43.05%39.28M-34.80%152.48M-33.08%115.66M-42.05%75.99M-58.49%27.46M11.77%233.88M
Total composite income of parent company owners -7.74%35.29M2.86%165.19M1.65%120.94M16.53%90.23M25.94%38.25M-29.15%160.6M-30.57%118.98M-40.95%77.43M-54.08%30.37M8.33%226.67M
Total composite income of minority owners -103.18%-32.64K79.75%-1.64M165.32%2.17M190.60%1.3M135.15%1.03M-212.58%-8.12M-328.33%-3.32M---1.44M---2.92M--7.21M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion------Unqualified opinion
Auditor --Zhonghui Certified Public Accountants (Special General Partnership)------Zhonghui Certified Public Accountants (Special General Partnership)------Zhonghui Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Petroleum
No. Symbol 20D % Chg
Sample Name
Sample Code
 +2.64%
Sample Name
Sample Code
 -0.13%
Sample Name
Sample Code
 -1.05%
4
SHANGHAI PECHEM
00338
-1.56%
5
SINOPEC CORP
00386
-2.39%
View More
No. Symbol 20D % Chg
Sample Name
Sample Code
 +41.26%
Sample Name
Sample Code
 +31.66%
Sample Name
Sample Code
 +26.25%
4
Digital China Group
000034
+15.29%
5
Loongson Technology Corporation
688047
+12.74%
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -